Skip to main content
. 2018 Aug 30;31(7-8):301–312. doi: 10.1093/protein/gzy018

Table II.

Loop sequences in engineered single or bivalent 10FN3 domain inhibitors

Constructsa AB loop CD loop EF loop FG loop
WTb TPTS GGNSP GLKPG GRGDSPASSK
FG (MOP3) SGGGSFAEYWALLSGGGSc
FGC (MOP3C) SGGGSAAEYAALASGGGSd
AB SGGGSFAEYWALLSGGGS
AB2 TPSFAEYWALLSTS
AB:FG SGGGSFAEYWALLSGGGS SGGGSFAEYWALLSGGGS
AB2:FG TPSFAEYWALLSTS SGGGSFAEYWALLSGGGS
CD SGGGSFAEYWALLSGGGS
CDC SGGGSAAEYAALASGGGS
CD:FG (MOP3+) SGGGSFAEYWALLSGGGS SGGGSFAEYWALLSGGGS
CDC:FG SGGGSAAEYAALASGGGS SGGGSFAEYWALLSGGGS
EF SGGGSFAEYWALLSGGGS
EF2 GLSFAEYWALLSKPG
EF: FG SGGGSFAEYWALLSGGGS SGGGSFAEYWALLSGGGS
EF2:FG GLSFAEYWALLSKPG SGGGSFAEYWALLSGGGS

aName of 10FN3 domain inhibitors based on loop where a replacement (AB, CD, EF or FG) or insertion was made (AB2, EF2).

bWild-type sequences of AB, CD, EF and FG loop region.

cSGGGSFAEYWALLSGGGS = SGGG-M2-GGGS.

dSGGGSAAEYAALASGGGS = SGGG-M2C-GGGS.